ESR1 and breast carcinoma: Triple negative breast cancers (TNBC) account for approximately 12% of breast cancers, and are defined as cancers that are hormone receptor negative, lacking significant expression of estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor (HER2) [2].